financetom
Business
financetom
/
Business
/
Altria Group Q2 Adjusted Earnings Rise, Revenue Falls; Updates 2025 Adjusted Earnings Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Altria Group Q2 Adjusted Earnings Rise, Revenue Falls; Updates 2025 Adjusted Earnings Guidance
Jul 30, 2025 4:49 AM

07:25 AM EDT, 07/30/2025 (MT Newswires) -- Altria Group ( MO ) reported Q2 adjusted earnings Wednesday of $1.44 per diluted share, up from $1.33 a year earlier.

Analysts polled by FactSet expected $1.39.

Net revenue for the quarter ended June 30 was $6.10 billion, down from $6.21 billion a year earlier.

Analysts surveyed by FactSet expected $5.19 billion.

The company said it raised the lower end of its 2025 adjusted earnings guidance to $5.35 to $5.45 per share. That compares with $5.30 to $5.45 previously. Analysts polled by FactSet expect $5.38.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
J&J plans to invest more than $55 billion in US over next four years
J&J plans to invest more than $55 billion in US over next four years
Mar 21, 2025
(Reuters) -Johnson & Johnson said on Friday it plans to invest more than $55 billion over the next four years to build manufacturing facilities and research infrastructure in the United States. The drug and device maker said this represents an increase of 25% in investment compared to the past four years. The company plans to build three new manufacturing facilities...
FOCUS-Gene therapy loses luster as investors eye quicker returns from weight-loss drugs
FOCUS-Gene therapy loses luster as investors eye quicker returns from weight-loss drugs
Mar 21, 2025
* Venture capital investment in gene therapies fell to $1.4 billion in 2024 from 2021 peak of $8.2 billion * Total global biopharma venture funding rose to $27 billion in 2024 from $23.2 billion in 2023 * Manufacturing, commercial hurdles limit demand for some gene therapies By Deena Beasley March 21 (Reuters) - Gene therapy, with its offer of a...
Tom Cruise, Superman and 'Avatar' hold keys to 2025 box office
Tom Cruise, Superman and 'Avatar' hold keys to 2025 box office
Mar 21, 2025
LOS ANGELES, March 21 (Reuters) - Tom Cruise takes on what may be his final Mission: Impossible, a new Superman will wear the red cape, and the record-setting Avatar sci-fi series will return to movie theaters this year. Those films and more are giving cinema operators hope that the long recovery from the COVID-19 pandemic will continue in 2025. Five...
ING Comments on Euro, Swiss Franc, Sweden's Krona, Sterling, Turkey's Lira
ING Comments on Euro, Swiss Franc, Sweden's Krona, Sterling, Turkey's Lira
Mar 21, 2025
06:13 AM EDT, 03/21/2025 (MT Newswires) -- European Central Bank President Christine Lagarde stuck to a strictly neutral tone in her European Parliament speech on Thursday, said ING. It's admittedly hard to ask for anything different than rigorous data dependency at a time where uncertainty on the tariff impact is paired with uncertainty about fiscal stimulus implications. In other words,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved